Characterisation of Fractalkine/CX3CL1 and Fractalkine Receptor (CX3CR1) Expression in Abdominal Aortic Aneurysm Disease

European Journal of Vascular and Endovascular Surgery

Volumn 36, Issue 1, 2008, Pages 20-27

  Patel, A ^a   Jagadesham, V P ^a,b   Porter, K E ^a   Scott, D J A ^b   Carding, S R ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Aneurysm; Aorta; Fractalkine; Inflammation; NK cells

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; ADULT; ADVENTITIA; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL INTERACTION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATORY CELL; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

AGED; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CX3CL1; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45849126893     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2008.01.014     Document Type: Article

References (33)

1. MacSweeney S.T., Powell J.T., and Greenhalgh R.M. Pathogenesis of abdominal aortic aneurysm. Br J Surg 81 7 (1994 Jul) 935-941
2. Thompson M.M., Jones L., Nasim A., Sayers R.D., and Bell P.R. Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 11 4 (1996 May) 464-469
3. Forester N.D., Cruickshank S.M., Scott D.J., and Carding S.R. Increased natural killer cell activity in patients with an abdominal aortic aneurysm. Br J Surg 93 1 (2006 Jan) 46-54
4. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 6676 (1998 Apr 9) 565-568
5. Damas J.K., Boullier A., Waehre T., Smith C., Sandberg W.J., Green S., et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol 25 12 (2005 Dec) 2567-2572
6. Lucas A.D., Bursill C., Guzik T.J., Sadowski J., Channon K.M., and Greaves D.R. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 108 20 (2003 Nov 18) 2498-2504
7. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 385 6617 (1997 Feb 13) 640-644
8. Fraticelli P., Sironi M., Bianchi G., D'Ambrosio D., Albanesi C., Stoppacciaro A., et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107 9 (2001 May) 1173-1181
9. Xiong W., Zhao Y., Prall A., Greiner T.C., and Baxter B.T. Key roles of CD4 + T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. J Immunol 172 4 (2004 Feb 15) 2607-2612
10. Ollivier V., Faure S., Tarantino N., Chollet-Martin S., Deterre P., Combadiere C., et al. Fractalkine/CX3CL1 production by human aortic smooth muscle cells impairs monocyte procoagulant and inflammatory responses. Cytokine 21 6 (2003 Mar 21) 303-311
11. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91 4 (1997 Nov 14) 521-530
12. Yoneda O., Imai T., Goda S., Inoue H., Yamauchi A., Okazaki T., et al. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164 8 (2000 Apr 15) 4055-4062
13. Combadiere C., Potteaux S., Gao J.L., Esposito B., Casanova S., Lee E.J., et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107 7 (2003 Feb 25) 1009-1016
14. Porter K.E., Naik J., Turner N.A., Dickinson T., Thompson M.M., and London N.J. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg 36 1 (2002 Jul) 150-157
15. + signaling in human venous endothelial cells. Multiple roles for reactive oxygen species. J Biol Chem 280 14 (2005 Apr 8) 13349-13354
16. Latchney L.R., Fallon M.A., Culp D.J., Gelbard H.A., and Dewhurst S. Immunohistochemical assessment of fractalkine, inflammatory cells, and human herpesvirus 7 in human salivary glands. J Histochem Cytochem 52 5 (2004 May) 671-681
17. Fong A.M., Robinson L.A., Steeber D.A., Tedder T.F., Yoshie O., Imai T., et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 188 8 (1998 Oct 19) 1413-1419
18. Blann A.D., and Pretorius A. Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?. Atherosclerosis 188 1 (2006 Sep) 12-18
19. Gonzalez M.L., Ruan X., Kumar P., Grammas P., and Pereira H.A. Functional modulation of smooth muscle cells by the inflammatory mediator CAP37. Microvasc Res 67 2 (2004 Mar) 168-181
20. Satoh H., Nakamura M., Satoh M., Nakajima T., Izumoto H., Maesawa C., et al. Expression and localization of tumour necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm. Clin Sci (Lond) 106 3 (2004 Mar) 301-306
21. Numano F. Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 75 Suppl. 1 (2000 Aug 31) S1-S8 [discussion S17-9]
22. Rasmussen T.E., Hallett Jr. J.W., Schulte S., Harmsen W.S., O'Fallon W.M., and Weyand C.M. Genetic similarity in inflammatory and degenerative abdominal aortic aneurysms: a study of human leukocyte antigen class II disease risk genes. J Vasc Surg 34 1 (2001 Jul) 84-89
23. Caligiuri G., Rossignol P., Julia P., Groyer E., Mouradian D., Urbain D., et al. Reduced immunoregulatory CD31+T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 26 3 (2006 Mar) 618-623
24. + monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol 80 5 (2006 Nov) 1156-1164
25. Nishimura M., Umehara H., Nakayama T., Yoneda O., Hieshima K., Kakizaki M., et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 168 12 (2002 Jun 15) 6173-6180
26. Bobryshev Y.V., Lord R.S., and Parsson H. Immunophenotypic analysis of the aortic aneurysm wall suggests that vascular dendritic cells are involved in immune responses. Cardiovasc Surg 6 3 (1998 Jun) 240-249
27. Dichmann S., Herouy Y., Purlis D., Rheinen H., Gebicke-Harter P., and Norgauer J. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm Res 50 11 (2001 Nov) 529-533
28. Wilmink T.B., Quick C.R., and Day N.E. The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 30 6 (1999 Dec) 1099-1105
29. Shiraya S., Miwa K., Aoki M., Miyake T., Oishi M., Kataoka K., et al. Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappaB and Ets. Hypertension 48 4 (2006 Oct) 628-636
30. Chandrasekar B., Mummidi S., Perla R.P., Bysani S., Dulin N.O., Liu F., et al. Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J 373 Pt 2 (2003 Jul 15) 547-558
31. Ludwig A., Berkhout T., Moores K., Groot P., and Chapman G. Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity. J Immunol 168 2 (2002 Jan 15) 604-612
32. Lindholt J.S., Heickendorff L., Henneberg E.W., and Fasting H. Serum-elastin-peptides as a predictor of expansion of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 14 1 (1997 Jul) 12-16
33. Blasi F., Denti F., Erba M., Cosentini R., Raccanelli R., Rinaldi A., et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 34 11 (1996 Nov) 2766-2769